• <u>Me</u>tabolic Acidosis, <u>H</u>yperkalemia, <u>and R</u>enal <u>U</u>nresponsiveness to Aldosterone Syndrome: Response to Treatment with Low-Potassium Diet
• 11Beta-hydroxylase deficiency and other syndromes of mineralocorticoid excess as a rare cause of endocrine hypertension
• A case of Chopra-Amiel-Gordon syndrome with a novel heterozygous variant in the <em>ANKRD17</em> gene: A case report
• A case of Chopra-Amiel-Gordon syndrome with a novel heterozygous variant in the ANKRD17 gene: A case report
• A Case of Pseudohypoaldosteronism Type Ⅱ (PHA2) Caused by a Novel Mutation of <em>KLHL</em>3
• A case report of Gordon's syndrome in a 20-year-old male with free medical family history
• A case report of pseudohypoaldosteronism type II with a homozygous KLHL3 variant accompanied by hyperthyroidism
• A genotype-phenotype correlation in split-hand/foot malformation type 1: further refinement of the phenotypic subregions within the 7q21.3 locus
• A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis
• A novel PIEZO2 mutation in a fetus from a Chinese family with Gordon syndrome
• A Novel Splice-Site Mutation in <em>VEGFC</em> Is Associated with Congenital Primary Lymphoedema of Gordon
• A rare case of persistent hyperkalaemia
• A Spanish Family with Gordon Syndrome Due to a Variant in the Acidic Motif of <em>WNK1</em>
• A Spanish Family with Gordon Syndrome Due to a Variant in the Acidic Motif of WNK1
• A WNK4 gene variant relates to osteoporosis and not to hypertension in the Portuguese population
• A young child with pseudohypoaldosteronism type II by a mutation of Cullin 3
• A young female with Spitzer-Weinstein syndrome diagnosed by thiazide test
• Associated syndromes in patients with Pierre Robin Sequence
• Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum
• c.1103T&gt;C (p.Ile368Th) de novo Variant in Synaptotagmin 1 (<em>SYT1</em>) Gene is Pathogenic, Leading to an Ultra-Rare Neurodevelopmental Disorder: The Baker-Gordon Syndrome
• c.1103T>C (p.Ile368Th) de novo Variant in Synaptotagmin 1 (SYT1) Gene is Pathogenic, Leading to an Ultra-Rare Neurodevelopmental Disorder: The Baker-Gordon Syndrome
• Cardiometabolic Parameters 3 Years After Switch to Dolutegravir/Lamivudine vs Maintenance of Tenofovir Alafenamide-Based Regimens
• Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease
• Challenges of Diagnosing Pseudohypoaldosteronism (PHA) in an Infant
• Channels, carriers, and pumps in the pathogenesis of sodium-sensitive hypertension
• Classification of pseudohypoaldosteronism type II as type IV renal tubular acidosis: results of a literature review
• Confirming the involvement of PIEZO2 in the etiology of Marden-Walker syndrome
• Consensus Paper: Cerebellum and Ageing
• Contribution of monogenic hypertension models to understanding of other hypertensions
• Crystal structure of domain-swapped STE20 OSR1 kinase domain
• Cullin 3 and Blood Pressure Regulation: Insights From Familial Hyperkalemic Hypertension
• Distal arthrogryposis type 5 and PIEZO2 novel variant in a Canadian family
• Does Gordon's syndrome always manifest as hypertension? - a case report of one family
• Elevated plasma asymmetric dimethyl-L-arginine in a patient with Gordon syndrome
• Expanding the genetic and phenotypic spectrum of Baker-Gordon syndrome: a new de novo SYT1 variant
• Extrarenal roles of the with-no-lysine[K] kinases (WNKs)
• Familial Gordon syndrome associated with a PIEZO2 mutation
• Familial hyperkalemic hypertension: hyperkalemia not hypertension defines dominant KLHL3 disease and may permit earlier recognition and tailored therapy
• Familial or genetic primary aldosteronism and Gordon syndrome
• Findings, Phenotypes, Diagnostic Accuracy, and Treatment in Freeman-Burian Syndrome
• Frailty in Younger Adults in Hospital
• Further Evidence of a Continuum in the Clinical Spectrum of Dominant <em>PIEZO2</em>-Related Disorders and Implications in Cerebellar Anomalies
• Genetics and arterial hypertension: monogenic forms
• Genotype-phenotype correlation in Gordon's syndrome: report of two cases carrying novel heterozygous mutations
• Gordon syndrome and succinylcholine
• Gordon syndrome caused by a <em>CUL3</em> mutation in a patient with short stature in Korea: a case report
• Gordon syndrome caused by a CUL3 mutation in a patient with short stature in Korea: a case report
• Gordon Syndrome: a continuing story
• Gordon syndrome: Dental implications and a case report
• Gordon syndrome: literature review and a report of two cases
• Gordon syndrome: The importance of measuring blood pressure in children
• Heterozygous rare variants in NR2F2 cause a recognizable multiple congenital anomaly syndrome with developmental delays
• Hyperkalemia and Hypertension Post Organ Transplantation - A Management Challenge
• Hypertension Accompanied by Hyperaldosteronism, Hyperkalemia, and Hyperchloremic Acidosis: A Case Report and Literature Review
• Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT
• Inherited Na transport disorders: the taming of the syndromes
• Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension
• Instrumented arthrodesis for non-traumatic craniocervical instability in very young children
• Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4
• Kelch-like protein 3 in human disease and therapy
• Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder
• Lethal respiratory course and additional features expand the phenotypic spectrum of PIEZO2-related distal arthrogryposis type 5
• Lethal variant in the C2A domain may cause severe SYT1-associated neurodevelopmental disorder in the newborns
• Long-term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID-19: A 2.5-year follow-up study
• Low-Renin Hypertension
• Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques
• Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia
• Monogenic Etiology of Hypertension
• Monogenic Forms of Hypertension
• Monogenic hypertension
• Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5
• Mutations in PIEZO2 contribute to Gordon syndrome, Marden-Walker syndrome and distal arthrogryposis: A bioinformatics analysis of mechanisms
• Nephron Remodeling Underlies Hyperkalemia in Familial Hyperkalemic Hypertension
• Novel <em>KLHL3</em> Variant in an Infant With Gordon Syndrome
• Novel KLHL3 Variant in an Infant With Gordon Syndrome
• Novel polymorphic AluYb8 insertion in the WNK1 gene is associated with blood pressure variation in Europeans
• Overview of Monogenic or Mendelian Forms of Hypertension
• Pediatric Acute Respiratory Distress Syndrome in South African PICUs: A Multisite Point-Prevalence Study
• Piezo proteins: regulators of mechanosensation and other cellular processes
• Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity
• Pseudohypoaldosteronism Type II or Gordon Syndrome: A Rare Syndrome of Hyperkalemia and Hypertension With Normal Renal Function
• Pseudohypoaldosteronism Type II: A Young Girl Presented with Hypertension, Hyperkalemia and Metabolic Acidosis
• Rare cause of severe hypertension in an adolescent boy presenting with short stature: Answers
• Regulation of kidney on potassium balance and its clinical significance
• Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved
• Renal and brain isoforms of WNK3 have opposite effects on NCCT expression
• Renal sodium and magnesium reabsorption are not coupled in a mouse model of Gordon syndrome
• Renal tubular transport and the genetic basis of hypertensive disease
• SPAK and WNK kinases: a new target for blood pressure treatment?
• Spectrum of renin angiotensin aldosterone system disorders in young hypertensives
• The association between hypertensive disorders during pregnancy and maternal and neonatal outcomes: a retrospective claims analysis
• The kidney and hypertension: lessons from mouse models
• The Molecular Genetics of Gordon Syndrome
• The things we carry: The scope and impact of second victim syndrome
• Three cases of Gordon syndrome with dominant KLHL3 mutations
• Unanticipated domain requirements for Drosophila Wnk kinase in vivo
• Validation of the Observer-Reported Communication Ability (ORCA) measure for individuals with Rett syndrome
• WNK1 affects surface expression of the ROMK potassium channel independent of WNK4
• WNK1 and WNK4, new players in salt and water homeostasis
• WNKs in Wnt/β-catenin signaling